Med Page Today
NOVEMBER 3, 2024
(MedPage Today) -- Investigational transcranial magnetic stimulation that targeted a brain network involved in memory slowed progression in mild-to-moderate Alzheimer's disease, data from a small phase II study suggested. At 1 year, noninvasive.
Journal of Cardiothoracic Surgery
NOVEMBER 3, 2024
Ingested dental prosthesis are susceptible to impaction in the gastrointestinal tract due to their sharp edges, size and contour. Delays in presentation arise from the lack of clear history of ingestion and mi.
Heart Sisters
NOVEMBER 3, 2024
What’s the deal with eggs if you have heart concerns? Registered Dietitian Cheryl Strachan wades through conflicting studies for us.
Circulation
NOVEMBER 3, 2024
Circulation, Volume 150, Issue 19 , Page 1481-1483, November 5, 2024.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
European Journal of Heart Failure
NOVEMBER 3, 2024
Guideline directed medical therapy (GDMT)-centred decongestion in heart failure (HF). ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin receptorneprilysin inhibitor; CVP, central venous pressure; MRA, mineralocorticoid receptor antagonist; PCWP, pulmonary capillary wedge pressure; RAAS, reninangiotensinaldosterone system; SGLT-2i, sodiumglucose cotransporter 2 inhibitor; SNS, sympathetic nervous system.
Journal of Cardiovascular Electrophysiology
NOVEMBER 3, 2024
Abstract Background and Aims Atrial fibrillation is the most prevalent cardiac arrhythmia, and catheter ablation (CA) has emerged as a viable treatment option for selected patients. However, its safety profile in liver cirrhosis (LC) populations remains underexplored. Methods This was an observational analysis of the National Inpatient Sample Database 20162020; we analyzed adult encounters undergoing CA for atrial fibrillation who had a concomitant diagnosis of LC.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Cardiovascular Ultrasound
NOVEMBER 3, 2024
Atrial cardiomyopathy is closely associated with atrial fibrillation (AF), and some patients exhibit no dysfunction at rest but demonstrate evident changes in left atrial (LA) function and LA volume during exe.
Cardiovascular Diabetology
NOVEMBER 3, 2024
Plasma ceramide plays a potentially significant role in the pathogenesis of coronary microvascular dysfunction. However, the relationship between plasma ceramide and coronary microvascular resistance in patien.
Journal of Cardiothoracic Surgery
NOVEMBER 3, 2024
Cardiac hemangioma is a rare, benign vascular primary tumor. Clinical presentation is either asymptomatic or with symptoms due to its location and spatial interaction with adjacent structures. The authors pres.
HCPLive
NOVEMBER 3, 2024
The rheumatology month in review emphasizes new data on secukinumab, gout clinical decision making, and addressing sleep issues in fibromyalgia.
Circulation
NOVEMBER 3, 2024
Circulation, Volume 150, Issue 19 , Page 1505-1507, November 5, 2024.
European Journal of Heart Failure
NOVEMBER 3, 2024
Abstract Aims Atrial fibrillation (AF) is common in heart failure (HF) and negatively impacts outcomes. The role of ablation-based rhythm control in patients with AF and HF with preserved (HFpEF) or mildly reduced ejection fraction (HFmrEF) is not known. The CABA-HFPEF-DZHK27 (CAtheter-Based Ablation of atrial fibrillation compared to conventional treatment in patients with Heart Failure with Preserved Ejection Fraction) trial will determine whether early catheter ablation for AF can prevent adv
Circulation
NOVEMBER 3, 2024
Circulation, Volume 150, Issue 19 , Page 1487-1489, November 5, 2024.
European Journal of Heart Failure
NOVEMBER 3, 2024
EASY-HF: readily available urinary sodium analysis in patients with acute decompensated heart failure (ADHF). GFR, glomerular filtration rate; NTproBNP, N-terminal pro-B-type natriuretic peptide; POC, point of care; RCT, randomized controlled trial; SOC, standard of care; UNa, urinary sodium concentration. Aims Early evaluation of the natriuretic response is recommended to guide diuretic therapy in acute decompensated heart failure (ADHF).
Dr. Smith's ECG Blog
NOVEMBER 3, 2024
Written by Magnus Nossen ( with comments and laddergram by Ken Grauer ) The patient in today’s case is a man in his 60s — who presented with palpitations and lightheadedness. He had no history of syncope. The patient had hypertension, but was otherwise healthy. Due to the reported symptoms, he was admitted for observation and put on telemetry monitoring.
European Journal of Heart Failure
NOVEMBER 3, 2024
Development and validation of a machine-learning approach to identify diabetic cardiomyopathy. A, A velocity; ARIC, Atherosclerosis Risk in Communities; CHS, Cardiovascular Health Study; CVD, cardiovascular disease; DbCM, diabetic cardiomyopathy; DeepNN, deep neural network; E, E velocity; EHR, electronic health record; HF, heart failure; LA, left atrial; LVEDV, left ventricular end-diastolic volume; LV, left ventricular; NT-proBNP, N-terminal pro-B-type natriuretic peptide; T2D, type 2 diabetes
CardiacWire
NOVEMBER 3, 2024
This year’s TCT conference saw a deluge of TAVR studies examining everything from the efficacy of valve designs to TAVR’s impact on aortic and tricuspid regurgitation. Out of all these TAVR studies, the four that could have the greatest clinical impact focused on interventional timing and the risk of comorbidities and procedural complications. The EARLY TAVR trial shined the brightest spotlight on TAVR timing, finding that earlier intervention in patients with asymptomatic severe AS may be more
Journal of Cardiovascular Electrophysiology
NOVEMBER 3, 2024
Abstract Objective The potential risk of inducing ventricular arrhythmias was explored by employing pulsed field ablation (PFA) through the administration of both monophasic and biphasic waveform deliveries. Methods PFA was applied to specific locations in the right ventricle (RV, n = 5 sites) in swine ( n = 2), utilizing identical settings with consistent amplitude, pulse width, and a number of pulses for both monophasic and biphasic waveforms.
Expert insights. Personalized for you.
127 
Let's personalize your content